Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.07
+0.06 (0.86%)
At close: Jul 24, 2026, 4:00 PM EDT
7.02
-0.05 (-0.71%)
After-hours: Jul 24, 2026, 7:41 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $436.59 million as of July 24, 2026. Its market cap has increased by 41.40% in one year.
Market Cap
436.59M
Enterprise Value
332.09M
1-Year Change
41.40%
Ranking
Category
Stock Price
$7.07
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $436.59M, an increase of 23.05%. That is a compound annual growth rate of 7.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 436.59M | 126.76% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 462.15M |
| Kyverna Therapeutics | 449.88M |
| Cabaletta Bio | 448.40M |
| Ovid Therapeutics | 444.20M |
| Prothena Corporation | 441.86M |
| Ocugen | 436.69M |
| Editas Medicine | 426.62M |
| Eupraxia Pharmaceuticals | 422.07M |